Radiation-induced p53 and p21(WAF-1/CIP1) expression in the murine intestinal epithelium: Apoptosis and cell cycle arrest

American Journal of Pathology

Volumn 153, Issue 3, 1998, Pages 899-909

  Wilson, James W ^a   Mark Pritchard, D ^a,b   Hickman, John A ^b   Potten, Christopher S ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P21; PROTEIN P53;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; GENE MUTATION; HOMOZYGOSITY; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM; INTESTINE INJURY; IONIZING RADIATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RADIATION INJURY;

EID: 3543029166     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65631-3     Document Type: Article

References (52)

1. Jackson SP: The recognition of DNA damage. Curr Opin Genet Dev 1996, 6:19-25.
2. Kastan MB, Onyckwere O, Sidransky D, Vogelstein B, Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991, 51:6304-6311
3. Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace AJ Jr: A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia telangiectasia. Cell 1992, 71:587-597
4. Wood RD. DNA repair in eukaryotes. Annu Rev Biochem 1996, 65: 135-167.
5. Reed JC. Double identity for proteins of the Bcl-2 family. Nature 1997, 387:773-776.
6. Maltzman W, Czyzyk L. UV irradiation stimulates levels of p53 cellular tumor antigen in non-transformed mouse cells. Mol Cell Biol 1984, 4:1689-1694.
7. Tishler RB, Calderwood SK, Coleman CN, Price BD. Increases in sequence-specific DNA binding by p53 following treatment with chemotherapeutic and DNA-damaging agents. Cancer Res 1993, 53 (Suppl 10):2212-2216.
8. Graeber TG, Peterson JF, Tsai M, Monica K, Fornace AJ Jr, Giaccia AJ: Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol Cell Biol 1994, 14:6264-6277
9. Amson RB, Nemani M, Roperch J-P, Israeli D, Bougueleret L, LeGall I, Medhioub M, Linares-Cruz G, Lethrosne F, Pasturaud P, Piouffre L, et al. Isolation of 10 differentially expressed cDNAs in p53-induced apoptosis: activation of the vertebrate homologue of the Drosophila seven in absentia gene. Proc Natl Acad Sci USA 1996, 93:3953-3957
10. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model for p53-induced apoptosis. Nature 1997, 389:300-305
11. Murphy M, Hinman A, Levine AJ. Wild type p53 negatively regulates the expression of a microtubule-associated protein. Genes Dev 1996, 10-2971-2980
12. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 1993, 75:817-825
13. Dulic V, Kauffman WK, Wilson SJ, Tisty TD, Lees E, Harper JW, Elledge SJ, Reed SI. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 1994, 76:1013-1023
14. Selvakumaran M, Lin H-K, Miyashita T, Wang HG, Krajewski S, Reed JC, Hoffman B, Liebermann D. Immediate early up-regulation of bax expression by p53 but not TGFβ1 : a paradigm for distinct apoptotic pathways. Oncogene 1994, 9:1791-1798
15. Zhan Q, Fan S, Bae I, Guillouf C, Liebermann DA, O'Connor PM, Fornace AJ: Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene 1994, 9:3743-3751.
16. Miyashita T, Reed JC. Tumour suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995, 80:293-299
17. Wu G-S, Burns TF, McDonald ER III, Jiang W, Meng R, Krantz ID, Kao G, Gan D-D, Zhou J-Y, Muschel R, Hamilton SR, Spinner NB, Markowitz S, Wu G, El-Deiry WS. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat Genet 1997, 17:141-143
18. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T, Hannon GJ. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 1995, 377:552-557
19. 1 arrest in human cancer cells. Cancer Res 1995, 55:5187-5190
20. Del Sal G, Murphy M, Ruaro EM, Lazarevic D, Levine AJ, Schneider C. Cyclin D1 and p21/waf1 are both involved in p53 growth suppression. Oncogene 1996, 12:177-185
21. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi, R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 1993, 366:701-704
22. Waga S, Hannon GJ, Beach D, Stillman B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 1994, 369:574-578
23. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 1994, 211:90-98
24. CIP1/WAF1 gene in normal diploid human fibroblasts. Science 1997, 277:831-834
25. Merritt AJ, Potten CS, Kemp CJ, Hickman JA, Balmam A, Lane DP, Hall PA. The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Res 1994, 54:614-617
26. Merritt AJ, Allen TD, Potten CS, Hickman JA. Apoptosis in small intestinal epithelia from p53-null mice: evidence for a delayed, p53-independent G2/M-associated cell death after γ-irradiation. Oncogene 1997, 14:2759-2766
27. Clarke AR, Gledhill S, Hooper ML, Bird CC, Wyllie AH. p53 dependence of early apoptotic and proliferation responses within the mouse intestinal epithelium following γ-irradiation. Oncogene 1994, 9:1767-1773
28. Clarke AR, Howard LA, Harrison DJ, Winton DJ. p53, mutation frequency and apoptosis in the murine small intestine. Oncogene 1997, 14:2015-2018
29. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, Butel JS, Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992, 356: 215-221
30. Wilson JW, Potten CS. Immunohistochemical localization of BAX and BAD in the normal and BCL-2 null gastrointestinal tract. Apoptosis 1996, 1:183-190
31. Ijiri K, Potten CS. Response of intestinal cells of differing topographical and hierarchical status to ten cytotoxic drugs and five sources of radiation. Br J Cancer 1983, 47:175-185
32. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972, 26:239-257
33. Potten CS. Effects of radiation on murine gastrointestinal cell proliferation. Radiation and Gut. Edited by CS Potten, JH Hendry Amsterdam: Elsevier Science BV, 1995, pp 61-84
34. Arai T, Kida Y, Harmon BV, Gobe GC. Comparative alterations in p53 expression and apoptosis in the irradiated rat small and large intestine. Br J Cancer 1996, 74:406-412
35. Chen X, Ko LJ, Jayaraman L, Prives C. p53 levels, functional domains and DNA damage determine the extent of the apoptotic response of tumor cells. Gene Dev 1996, 10:2438-2451
36. Lassus P, Ferlin M, Piette J, Hibner U. Anti-apoptotic activity of low levels of wild-type p53. EMBO J 1996, 15:4566-4573
37. Ronen D, Schwartz D, Teitz Y, Goldfinger N, Rotter V. Induction of HL-60 cells to undergo apoptosis is determined by high levels of wild-type p53 protein, whereas differentiation of the cells is mediated by lower p53 levels. Cell Growth Differ 1996, 7:21-30
38. Friedlander P, Haupt Y, Prives C, Oren M. A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis. Mol Cell Biol 1996, 16:4961-4971
39. Ludwig RL, Bates S, Vousden KH. Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function. Mol Cell Biol 1996, 16:4952-4960
40. Gottlieb E, Haffner R, King A, Asher G, Gruss P, Lonai P, Oren M. Transgenic mouse model for studying the transcriptional activity of the p53 protein: age- and tissue-dependent changes in radiation-induced activation during embryogenesis. EMBO J 1997, 16:1381-1390
41. Komarova EA, Chernov MV, Franks R, Wang K, Armin G, Zelnick CR, Chin DM, Bacus SS, Strark GR, Gudkov AV. Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo. EMBO J. 1997, 16:1391-1400
42. Chen J, Wu X, Lin J, Levine AJ. mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein. Mol Cell Biol 1996, 16:2445-2452
43. Haupt Y, Barak Y, Oren M. Mdm2 promotes the rapid degradation of p53. Nature 1997, 387:296-299
44. Midgley CA, Lane DP. p53 protein stability in tumour cells is not directly determined by mutation but is dependent on Mdm2 binding. Oncogene 1997, 15:1179-1189
45. Shieh S-Y, Ikeda M, Taya Y, Prives C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 1997, 91:325-334
46. Tanaka N, Ishihara M, Lamphier MS, Nozawa H, Matsuyama T, Mak TW, Aizawa S, Tokino T, Oren M, Taniguchi T. Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage. Nature 1996, 382:816-818
47. ING1 cooperates with p53 in cell growth control. Nature 1998, 391:295-298
48. Waldman T, Lengauer C, Kinzler KW, Vogelstein B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 1996, 381:713-716
49. Waldman T, Zhang Y, Dillehay L, Yu J, Kinzler K, Vogelstein B, Williams J. Cell-cycle arrest versus cell death in cancer therapy. Nat Med 1997, 3:1034-1036
50. WAF-1/CIP1 sensitizes tumors to radiation by an apoptosis-independent mechanism. Cancer Res 1997, 57:4703-4706
51. Polyak K, Waldman T, He T-C, Kinzler KW, Vogelstein B. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev 1996, 10:1945-1952
52. Potten CS. Structure, function and proliferative organisation of mammalian gut. Radiation and Gut. Edited by CS Potten, JH Hendry. Amsterdam, Elsevier Science BV, 1995, pp 1-31